Harvard Apparatus Regenerative Technology, Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Harvard Apparatus Regenerative Technology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • Harvard Apparatus Regenerative Technology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.86M, a 14.5% decline year-over-year.
  • Harvard Apparatus Regenerative Technology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.19M, a 5.38% increase year-over-year.
  • Harvard Apparatus Regenerative Technology, Inc. annual Operating Income (Loss) for 2023 was -$8.99M, a 46.1% decline from 2022.
  • Harvard Apparatus Regenerative Technology, Inc. annual Operating Income (Loss) for 2022 was -$6.15M, a 28.8% increase from 2021.
  • Harvard Apparatus Regenerative Technology, Inc. annual Operating Income (Loss) for 2021 was -$8.64M, a 62.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$8.19M -$1.86M -$235K -14.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$7.95M -$2.48M +$170K +6.41% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$8.12M -$2.02M +$866K +30% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$8.99M -$1.83M -$335K -22.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$8.66M -$1.62M -$544K -50.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$8.11M -$2.65M -$1.28M -92.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$6.84M -$2.89M -$682K -30.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$6.15M -$1.49M +$4.41M +74.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$10.6M -$1.08M -$258K -31.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$10.3M -$1.38M -$457K -49.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$9.85M -$2.21M -$1.21M -122% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$8.64M -$5.9M -$4.79M -432% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$3.85M -$822K +$236K +22.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$4.08M -$918K +$343K +27.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$4.42M -$995K +$901K +47.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$5.33M -$1.11M +$559K +33.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$5.88M -$1.06M +$1.44M +57.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$7.33M -$1.26M +$1.41M +52.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$8.73M -$1.9M +$138K +6.79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$8.87M -$1.67M +$431K +20.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-13
Q3 2019 -$9.3M -$2.5M -$271K -12.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$9.03M -$2.67M -$635K -31.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$8.4M -$2.03M -$554K -37.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$7.84M -$2.1M -$659K -45.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$7.18M -$2.23M +$1.02M +31.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$8.21M -$2.03M +$1.69M +45.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$9.9M -$1.48M +$1.57M +51.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$11.5M -$1.44M +$2.14M +59.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$13.6M -$3.25M -$103K -3.27% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$13.5M -$3.73M -$805K -27.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$12.7M -$3.05M -$576K -23.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$12.1M -$3.58M -$1.29M -56.5% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-17
Q3 2016 -$10.8M -$3.15M -$857K -37.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-12-15
Q2 2016 -$9.98M -$2.92M +$1.58M +35.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$11.6M -$2.47M +$148K +5.65% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$11.7M -$2.29M +$552K +19.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$12.3M -$2.29M +$384K +14.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-17
Q2 2015 -$12.6M -$4.5M -$1.97M -77.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-17
Q1 2015 -$10.7M -$2.62M +$386K +12.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
Q4 2014 -$11.1M -$2.84M -$194K -7.33% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$10.9M -$2.68M -$616K -29.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$10.2M -$2.53M -$444K -21.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$9.8M -$3.01M -$986K -48.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
Q4 2013 -$8.82M -$2.65M -$682K -34.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$8.14M -$2.06M -$332K -19.2% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-27
Q2 2013 -$7.8M -$2.09M -$325K -18.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-27
Q1 2013 -$7.48M -$2.02M -$765K -61% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-27
Q4 2012 -$6.71M -$1.97M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$1.73M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-31
Q2 2012 -$1.76M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-31
Q1 2012 -$1.26M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.